Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior Therapy | 12 | 2020 | 125 | 3.450 |
Why?
|
| Counseling | 12 | 2020 | 173 | 3.110 |
Why?
|
| Mass Screening | 13 | 2020 | 693 | 2.170 |
Why?
|
| Primary Health Care | 13 | 2020 | 729 | 1.920 |
Why?
|
| Advisory Committees | 7 | 2022 | 112 | 1.700 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 642 | 1.280 |
Why?
|
| Cardiovascular Diseases | 6 | 2022 | 545 | 1.200 |
Why?
|
| Depression | 7 | 2019 | 507 | 1.150 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2020 | 52 | 1.130 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 27 | 1.030 |
Why?
|
| Sexual Behavior | 2 | 2020 | 129 | 1.000 |
Why?
|
| Humans | 60 | 2022 | 17622 | 0.930 |
Why?
|
| Health Behavior | 5 | 2020 | 348 | 0.880 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 208 | 0.880 |
Why?
|
| Weight Loss | 3 | 2018 | 298 | 0.810 |
Why?
|
| United States | 18 | 2022 | 3922 | 0.800 |
Why?
|
| Suicide | 3 | 2013 | 116 | 0.780 |
Why?
|
| Feces | 3 | 2020 | 89 | 0.770 |
Why?
|
| Minerals | 1 | 2022 | 7 | 0.740 |
Why?
|
| Prescription Drugs | 2 | 2020 | 30 | 0.730 |
Why?
|
| Anti-Obesity Agents | 3 | 2018 | 18 | 0.720 |
Why?
|
| Antidepressive Agents | 4 | 2019 | 142 | 0.720 |
Why?
|
| Vitamins | 1 | 2022 | 59 | 0.710 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 417 | 0.690 |
Why?
|
| Adult | 28 | 2022 | 7621 | 0.630 |
Why?
|
| Health Education | 1 | 2020 | 82 | 0.620 |
Why?
|
| Risk Reduction Behavior | 3 | 2020 | 102 | 0.600 |
Why?
|
| Adolescent | 22 | 2020 | 3625 | 0.600 |
Why?
|
| Exercise | 3 | 2020 | 538 | 0.590 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 354 | 0.590 |
Why?
|
| Health Risk Behaviors | 1 | 2018 | 5 | 0.580 |
Why?
|
| Obesity Management | 1 | 2018 | 4 | 0.570 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 164 | 0.570 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 48 | 0.550 |
Why?
|
| Preventive Health Services | 4 | 2021 | 147 | 0.530 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 193 | 0.530 |
Why?
|
| Female | 32 | 2020 | 12715 | 0.520 |
Why?
|
| Neoplasms | 1 | 2022 | 457 | 0.520 |
Why?
|
| Asthma | 11 | 2007 | 401 | 0.460 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 101 | 0.460 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 173 | 0.440 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 559 | 0.440 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2015 | 213 | 0.440 |
Why?
|
| Obesity | 3 | 2018 | 821 | 0.440 |
Why?
|
| Male | 26 | 2020 | 10014 | 0.440 |
Why?
|
| Pregnancy | 7 | 2020 | 1565 | 0.370 |
Why?
|
| Psychotherapy | 4 | 2020 | 56 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 319 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 323 | 0.330 |
Why?
|
| Aspirin | 3 | 2016 | 63 | 0.320 |
Why?
|
| Primary Prevention | 2 | 2022 | 61 | 0.300 |
Why?
|
| Middle Aged | 18 | 2020 | 7954 | 0.280 |
Why?
|
| Stomach | 1 | 2008 | 4 | 0.280 |
Why?
|
| Laparoscopy | 1 | 2008 | 46 | 0.270 |
Why?
|
| Gastric Bypass | 1 | 2008 | 70 | 0.260 |
Why?
|
| Child | 8 | 2020 | 2485 | 0.250 |
Why?
|
| Risk Assessment | 6 | 2014 | 1093 | 0.250 |
Why?
|
| Aged | 12 | 2020 | 6223 | 0.250 |
Why?
|
| Young Adult | 3 | 2020 | 2538 | 0.250 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 121 | 0.240 |
Why?
|
| Incidence | 5 | 2020 | 1278 | 0.240 |
Why?
|
| Hypertension | 3 | 2020 | 486 | 0.220 |
Why?
|
| Overweight | 4 | 2017 | 266 | 0.220 |
Why?
|
| Surveys and Questionnaires | 8 | 2020 | 1296 | 0.220 |
Why?
|
| Age Factors | 3 | 2020 | 874 | 0.210 |
Why?
|
| Pre-Eclampsia | 2 | 2014 | 41 | 0.210 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1157 | 0.200 |
Why?
|
| Dietary Supplements | 2 | 2022 | 85 | 0.200 |
Why?
|
| Vitamin A | 1 | 2022 | 14 | 0.190 |
Why?
|
| beta Carotene | 1 | 2022 | 17 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2020 | 1251 | 0.180 |
Why?
|
| Marijuana Abuse | 2 | 2020 | 37 | 0.180 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 302 | 0.180 |
Why?
|
| Quality of Life | 4 | 2007 | 505 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 22 | 0.170 |
Why?
|
| Lactones | 3 | 2017 | 11 | 0.170 |
Why?
|
| Health Maintenance Organizations | 7 | 2005 | 403 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 39 | 0.170 |
Why?
|
| Risk Factors | 7 | 2019 | 3291 | 0.170 |
Why?
|
| Narration | 1 | 2020 | 8 | 0.170 |
Why?
|
| Depressive Disorder, Major | 3 | 2009 | 98 | 0.170 |
Why?
|
| Language | 1 | 2020 | 52 | 0.160 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 114 | 0.160 |
Why?
|
| Colonoscopy | 2 | 2020 | 265 | 0.160 |
Why?
|
| Adolescent Health Services | 2 | 2001 | 40 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2020 | 12 | 0.160 |
Why?
|
| Substance Abuse Detection | 1 | 2020 | 17 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2020 | 54 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2021 | 151 | 0.160 |
Why?
|
| Immunochemistry | 1 | 2020 | 20 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 23 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 121 | 0.150 |
Why?
|
| Serotonin Uptake Inhibitors | 3 | 2009 | 45 | 0.150 |
Why?
|
| Postal Service | 1 | 2020 | 72 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 208 | 0.150 |
Why?
|
| Public Health | 1 | 2020 | 84 | 0.150 |
Why?
|
| Sertraline | 1 | 2019 | 2 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2017 | 959 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2020 | 631 | 0.140 |
Why?
|
| Medicare | 1 | 2020 | 197 | 0.140 |
Why?
|
| Medicaid | 1 | 2020 | 188 | 0.140 |
Why?
|
| Occult Blood | 2 | 2016 | 162 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 278 | 0.140 |
Why?
|
| Prognosis | 1 | 2020 | 609 | 0.140 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 2 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 161 | 0.130 |
Why?
|
| Managed Care Programs | 5 | 2007 | 300 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2017 | 1455 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1107 | 0.130 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 14 | 0.130 |
Why?
|
| Metformin | 1 | 2017 | 52 | 0.130 |
Why?
|
| Treatment Outcome | 7 | 2011 | 1161 | 0.130 |
Why?
|
| Internet | 3 | 2017 | 207 | 0.120 |
Why?
|
| Body Weight | 1 | 2017 | 203 | 0.120 |
Why?
|
| Remission Induction | 1 | 2016 | 26 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 45 | 0.120 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 19 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 3 | 0.110 |
Why?
|
| Microsatellite Instability | 1 | 2015 | 16 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2015 | 11 | 0.110 |
Why?
|
| Adenoma | 1 | 2016 | 98 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 259 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 56 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2020 | 719 | 0.110 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 57 | 0.110 |
Why?
|
| Street Drugs | 1 | 2014 | 12 | 0.110 |
Why?
|
| Smoking Prevention | 1 | 2013 | 35 | 0.100 |
Why?
|
| Diet | 1 | 2014 | 355 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2005 | 186 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 99 | 0.090 |
Why?
|
| Patient Compliance | 2 | 2006 | 269 | 0.090 |
Why?
|
| Child of Impaired Parents | 2 | 2002 | 27 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 689 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2013 | 149 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 1038 | 0.090 |
Why?
|
| Dementia | 1 | 2013 | 136 | 0.080 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2010 | 23 | 0.080 |
Why?
|
| Data Collection | 3 | 2017 | 234 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2010 | 50 | 0.080 |
Why?
|
| Oregon | 6 | 2006 | 172 | 0.080 |
Why?
|
| Feedback | 1 | 2009 | 23 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2009 | 107 | 0.070 |
Why?
|
| Sex Counseling | 1 | 2008 | 2 | 0.070 |
Why?
|
| Telephone | 2 | 2006 | 159 | 0.070 |
Why?
|
| Unsafe Sex | 1 | 2008 | 18 | 0.070 |
Why?
|
| Organ Size | 1 | 2008 | 16 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 25 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 23 | 0.060 |
Why?
|
| Self Care | 2 | 2005 | 144 | 0.060 |
Why?
|
| Sick Role | 1 | 2006 | 9 | 0.060 |
Why?
|
| Self Concept | 1 | 2006 | 39 | 0.060 |
Why?
|
| Health Status | 3 | 2006 | 291 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2005 | 22 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2005 | 35 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 66 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2004 | 304 | 0.060 |
Why?
|
| Social Support | 1 | 2006 | 215 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2004 | 38 | 0.050 |
Why?
|
| Health Services | 2 | 2004 | 110 | 0.050 |
Why?
|
| Adolescent Behavior | 2 | 2014 | 123 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2002 | 88 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2001 | 15 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 363 | 0.040 |
Why?
|
| Health Equity | 1 | 2021 | 27 | 0.040 |
Why?
|
| Reinforcement, Social | 1 | 2001 | 1 | 0.040 |
Why?
|
| Cognitive Therapy | 1 | 2001 | 1 | 0.040 |
Why?
|
| Community Mental Health Services | 1 | 2001 | 33 | 0.040 |
Why?
|
| Aftercare | 1 | 2001 | 47 | 0.040 |
Why?
|
| Naloxone | 1 | 2020 | 19 | 0.040 |
Why?
|
| Food Analysis | 1 | 1999 | 5 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.040 |
Why?
|
| Parents | 1 | 2002 | 301 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2005 | 107 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 346 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 380 | 0.030 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 1998 | 1 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 1998 | 5 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 446 | 0.030 |
Why?
|
| Bias | 1 | 2017 | 95 | 0.030 |
Why?
|
| Colorado | 2 | 2007 | 170 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 26 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 28 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 26 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 45 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 65 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 26 | 0.030 |
Why?
|
| Health Surveys | 2 | 2006 | 242 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 179 | 0.030 |
Why?
|
| White Coat Hypertension | 1 | 2015 | 3 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 14 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 21 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 29 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 11 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 288 | 0.030 |
Why?
|
| Sex Factors | 2 | 2006 | 599 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2013 | 2 | 0.030 |
Why?
|
| Memantine | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 5 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 11 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 36 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2014 | 101 | 0.020 |
Why?
|
| Bupropion | 1 | 2013 | 9 | 0.020 |
Why?
|
| Algorithms | 2 | 2005 | 227 | 0.020 |
Why?
|
| Comorbidity | 2 | 2007 | 552 | 0.020 |
Why?
|
| Life Style | 1 | 2014 | 321 | 0.020 |
Why?
|
| Premature Birth | 1 | 2014 | 136 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 136 | 0.020 |
Why?
|
| Decision Making | 1 | 2013 | 177 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2011 | 22 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2005 | 237 | 0.020 |
Why?
|
| Psychotherapy, Group | 2 | 2001 | 20 | 0.020 |
Why?
|
| Calcium Compounds | 1 | 2010 | 3 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2010 | 15 | 0.020 |
Why?
|
| Washington | 2 | 2002 | 388 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 42 | 0.020 |
Why?
|
| Lipids | 1 | 2010 | 69 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 420 | 0.020 |
Why?
|
| Prevalence | 2 | 2004 | 830 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2010 | 5 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 55 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 75 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 71 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2010 | 15 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 76 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 163 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2009 | 60 | 0.020 |
Why?
|
| Psychometrics | 1 | 2007 | 119 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 92 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 84 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 119 | 0.020 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2006 | 13 | 0.020 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 2 | 0.010 |
Why?
|
| Respiratory System Agents | 1 | 2005 | 2 | 0.010 |
Why?
|
| Birth Order | 1 | 2005 | 4 | 0.010 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2005 | 3 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 13 | 0.010 |
Why?
|
| Medical Audit | 1 | 2005 | 32 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2006 | 214 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2005 | 8 | 0.010 |
Why?
|
| Maternal Age | 1 | 2005 | 74 | 0.010 |
Why?
|
| Cues | 1 | 2005 | 9 | 0.010 |
Why?
|
| Dermatitis, Atopic | 1 | 2005 | 18 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 166 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 324 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1295 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2005 | 211 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 174 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 67 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 368 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 230 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 143 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2002 | 35 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2001 | 11 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 44 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 475 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 2001 | 21 | 0.010 |
Why?
|
| Patient Selection | 1 | 2002 | 181 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 268 | 0.010 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2001 | 25 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2001 | 120 | 0.010 |
Why?
|
| Health Policy | 1 | 2001 | 106 | 0.010 |
Why?
|
| Child Health Services | 1 | 2001 | 107 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 80 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 337 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2502 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1998 | 4 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1998 | 7 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 55 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 23 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2001 | 276 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 831 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 1976 | 0.010 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->